retatrutide triple agonist Retatrutide: The first-in-class investigational receptor redefining Type 2 diabetes therapy Retatrutide Peptide: Triple Agonist Mechanism,
Pay in 4 interest-free payments of $6.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11





























